Gene Symbol | Gene ID | Gene Info |
---|---|---|
Pax6
|
ENSMUSG00000027168.15 | paired box 6 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr2_105668422_105670370 | Pax6 | 461 | 0.646038 | 0.69 | 1.1e-09 | Click! |
chr2_105678552_105679922 | Pax6 | 630 | 0.683557 | 0.67 | 3.7e-09 | Click! |
chr2_105680058_105680461 | Pax6 | 392 | 0.830643 | 0.65 | 1.7e-08 | Click! |
chr2_105675959_105678109 | Pax6 | 905 | 0.536341 | 0.65 | 2.1e-08 | Click! |
chr2_105670737_105671693 | Pax6 | 645 | 0.505730 | 0.64 | 4.1e-08 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr1_9601164_9602408 | 15.80 |
Vxn |
vexin |
587 |
0.67 |
chr2_113827975_113828215 | 15.22 |
Scg5 |
secretogranin V |
667 |
0.72 |
chr1_42703141_42704653 | 13.74 |
Pantr2 |
POU domain, class 3, transcription factor 3 adjacent noncoding transcript 2 |
4155 |
0.16 |
chr13_83736071_83736534 | 10.86 |
Gm33366 |
predicted gene, 33366 |
2233 |
0.18 |
chr4_5724213_5725550 | 10.58 |
Fam110b |
family with sequence similarity 110, member B |
569 |
0.81 |
chr13_110279614_110280243 | 10.36 |
Rab3c |
RAB3C, member RAS oncogene family |
222 |
0.95 |
chr1_66388178_66389004 | 10.25 |
Map2 |
microtubule-associated protein 2 |
1580 |
0.42 |
chr12_69907745_69908880 | 9.76 |
Atl1 |
atlastin GTPase 1 |
580 |
0.65 |
chr2_65566312_65566743 | 9.64 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
965 |
0.63 |
chr13_83737592_83739114 | 9.53 |
Gm33366 |
predicted gene, 33366 |
182 |
0.66 |
chr2_52860105_52860808 | 9.42 |
Fmnl2 |
formin-like 2 |
2588 |
0.39 |
chr3_68573207_68574269 | 9.37 |
Schip1 |
schwannomin interacting protein 1 |
1493 |
0.45 |
chrX_143930842_143933141 | 9.06 |
Dcx |
doublecortin |
1059 |
0.64 |
chr3_88210226_88210408 | 9.00 |
Gm3764 |
predicted gene 3764 |
845 |
0.35 |
chr2_25877424_25878675 | 8.97 |
Kcnt1 |
potassium channel, subfamily T, member 1 |
168 |
0.93 |
chr10_117478011_117478537 | 8.64 |
Gm32141 |
predicted gene, 32141 |
30781 |
0.13 |
chr12_46816152_46816702 | 8.39 |
Nova1 |
NOVA alternative splicing regulator 1 |
533 |
0.8 |
chr9_10903843_10905236 | 8.34 |
Cntn5 |
contactin 5 |
90 |
0.65 |
chrX_110817183_110817473 | 8.28 |
Pou3f4 |
POU domain, class 3, transcription factor 4 |
3048 |
0.3 |
chr1_172025134_172025920 | 8.10 |
Vangl2 |
VANGL planar cell polarity 2 |
1184 |
0.38 |
chr4_107718801_107719085 | 7.96 |
1700047F07Rik |
RIKEN cDNA 1700047F07 gene |
11886 |
0.11 |
chr8_70119024_70120981 | 7.77 |
Ncan |
neurocan |
871 |
0.35 |
chr2_90886739_90886966 | 7.73 |
C1qtnf4 |
C1q and tumor necrosis factor related protein 4 |
992 |
0.36 |
chr4_126465012_126466992 | 7.61 |
Ago1 |
argonaute RISC catalytic subunit 1 |
2419 |
0.18 |
chr12_88726779_88726984 | 7.60 |
Nrxn3 |
neurexin III |
1200 |
0.54 |
chr1_136584077_136584511 | 7.46 |
Gm33994 |
predicted gene, 33994 |
4817 |
0.15 |
chr9_41588484_41589112 | 7.46 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
304 |
0.82 |
chr6_114174111_114174845 | 7.45 |
Gm8132 |
predicted gene 8132 |
4955 |
0.24 |
chr10_90576163_90577493 | 7.33 |
Anks1b |
ankyrin repeat and sterile alpha motif domain containing 1B |
13 |
0.99 |
chr5_97222612_97223731 | 7.25 |
Gm2861 |
predicted gene 2861 |
27585 |
0.16 |
chr3_89243498_89245184 | 7.18 |
Trim46 |
tripartite motif-containing 46 |
672 |
0.36 |
chr6_39874717_39875333 | 7.07 |
Tmem178b |
transmembrane protein 178B |
1954 |
0.27 |
chr15_23035608_23036941 | 7.00 |
Cdh18 |
cadherin 18 |
181 |
0.97 |
chr3_94477599_94477954 | 6.94 |
Celf3 |
CUGBP, Elav-like family member 3 |
519 |
0.57 |
chr18_60925301_60926809 | 6.92 |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
330 |
0.84 |
chr9_52147545_52147787 | 6.84 |
Zc3h12c |
zinc finger CCCH type containing 12C |
20445 |
0.17 |
chrX_60895147_60896014 | 6.80 |
Gm14662 |
predicted gene 14662 |
1927 |
0.26 |
chr10_116017652_116019652 | 6.72 |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
365 |
0.92 |
chr6_93911862_93913573 | 6.65 |
Magi1 |
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
213 |
0.95 |
chr3_105453425_105453709 | 6.62 |
Kcnd3 |
potassium voltage-gated channel, Shal-related family, member 3 |
481 |
0.55 |
chr7_16959511_16960260 | 6.59 |
Pnmal1 |
PNMA-like 1 |
206 |
0.87 |
chr2_52557337_52558561 | 6.55 |
Cacnb4 |
calcium channel, voltage-dependent, beta 4 subunit |
611 |
0.74 |
chr10_122045908_122046333 | 6.51 |
Srgap1 |
SLIT-ROBO Rho GTPase activating protein 1 |
1188 |
0.41 |
chr17_43666249_43666745 | 6.51 |
Slc25a27 |
solute carrier family 25, member 27 |
635 |
0.52 |
chr6_121472749_121474141 | 6.49 |
Iqsec3 |
IQ motif and Sec7 domain 3 |
178 |
0.95 |
chr1_135602437_135602860 | 6.48 |
Nav1 |
neuron navigator 1 |
16943 |
0.17 |
chr1_129273098_129274282 | 6.46 |
Thsd7b |
thrombospondin, type I, domain containing 7B |
205 |
0.95 |
chr5_84281287_84281877 | 6.45 |
Epha5 |
Eph receptor A5 |
80484 |
0.11 |
chr8_84934799_84937325 | 6.45 |
Mast1 |
microtubule associated serine/threonine kinase 1 |
1282 |
0.19 |
chr13_83742301_83742867 | 6.37 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
3721 |
0.15 |
chr7_51510582_51511765 | 6.30 |
Ano5 |
anoctamin 5 |
66 |
0.98 |
chr3_76073782_76074914 | 6.26 |
Fstl5 |
follistatin-like 5 |
78 |
0.98 |
chr1_20892892_20893201 | 6.24 |
Paqr8 |
progestin and adipoQ receptor family member VIII |
2440 |
0.18 |
chr4_36952312_36953412 | 6.24 |
Gm12371 |
predicted gene 12371 |
104 |
0.95 |
chr1_193702771_193703234 | 6.19 |
Gm21362 |
predicted gene, 21362 |
164007 |
0.03 |
chr9_71892472_71892623 | 6.17 |
Tcf12 |
transcription factor 12 |
3438 |
0.15 |
chr11_80302268_80302834 | 6.13 |
Rhbdl3 |
rhomboid like 3 |
1639 |
0.38 |
chr14_52009953_52011160 | 6.09 |
Zfp219 |
zinc finger protein 219 |
19 |
0.94 |
chr6_134885665_134885822 | 6.01 |
Gpr19 |
G protein-coupled receptor 19 |
2025 |
0.2 |
chrX_60890535_60891315 | 6.00 |
Sox3 |
SRY (sex determining region Y)-box 3 |
2505 |
0.23 |
chr3_87621245_87621561 | 5.90 |
Arhgef11 |
Rho guanine nucleotide exchange factor (GEF) 11 |
2642 |
0.22 |
chr9_58197310_58202560 | 5.81 |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
637 |
0.54 |
chr17_62829101_62829482 | 5.80 |
Efna5 |
ephrin A5 |
51853 |
0.18 |
chr4_11964013_11964651 | 5.76 |
Pdp1 |
pyruvate dehyrogenase phosphatase catalytic subunit 1 |
1489 |
0.31 |
chrX_86191680_86192868 | 5.71 |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
510 |
0.82 |
chr2_50067554_50067705 | 5.66 |
Lypd6 |
LY6/PLAUR domain containing 6 |
1165 |
0.64 |
chr1_109982134_109982351 | 5.66 |
Cdh7 |
cadherin 7, type 2 |
189 |
0.97 |
chr18_76855816_76857376 | 5.63 |
Skor2 |
SKI family transcriptional corepressor 2 |
191 |
0.96 |
chr8_125996544_125996703 | 5.59 |
Kcnk1 |
potassium channel, subfamily K, member 1 |
1187 |
0.52 |
chr2_157914223_157915670 | 5.54 |
Vstm2l |
V-set and transmembrane domain containing 2-like |
293 |
0.91 |
chr5_120426818_120428597 | 5.53 |
Lhx5 |
LIM homeobox protein 5 |
3992 |
0.15 |
chr9_76322366_76323081 | 5.51 |
Hcrtr2 |
hypocretin (orexin) receptor 2 |
599 |
0.76 |
chr4_102762804_102762960 | 5.51 |
Sgip1 |
SH3-domain GRB2-like (endophilin) interacting protein 1 |
2357 |
0.36 |
chr5_53210934_53211705 | 5.50 |
Sel1l3 |
sel-1 suppressor of lin-12-like 3 (C. elegans) |
1996 |
0.35 |
chrX_49272929_49273965 | 5.46 |
Enox2 |
ecto-NOX disulfide-thiol exchanger 2 |
14765 |
0.24 |
chr2_6869935_6870654 | 5.46 |
Celf2 |
CUGBP, Elav-like family member 2 |
1678 |
0.39 |
chr19_25461815_25462365 | 5.44 |
Gm26207 |
predicted gene, 26207 |
8027 |
0.19 |
chr16_75447524_75447796 | 5.43 |
Gm49678 |
predicted gene, 49678 |
367 |
0.91 |
chr11_93101977_93102747 | 5.40 |
Car10 |
carbonic anhydrase 10 |
3072 |
0.4 |
chr12_49381569_49381963 | 5.35 |
Gm34304 |
predicted gene, 34304 |
119 |
0.91 |
chr12_67219298_67219500 | 5.34 |
Mdga2 |
MAM domain containing glycosylphosphatidylinositol anchor 2 |
1643 |
0.5 |
chr5_98180058_98181966 | 5.34 |
Prdm8 |
PR domain containing 8 |
34 |
0.97 |
chr7_118992109_118992499 | 5.33 |
Gprc5b |
G protein-coupled receptor, family C, group 5, member B |
2907 |
0.27 |
chr10_117994819_117995192 | 5.31 |
Gm37852 |
predicted gene, 37852 |
9933 |
0.2 |
chr13_69734884_69735178 | 5.26 |
Ube2ql1 |
ubiquitin-conjugating enzyme E2Q family-like 1 |
4858 |
0.14 |
chr7_140154045_140155011 | 5.25 |
Sprn |
shadow of prion protein |
349 |
0.75 |
chr15_25409748_25410224 | 5.24 |
Basp1 |
brain abundant, membrane attached signal protein 1 |
3712 |
0.18 |
chr7_119184137_119185474 | 5.22 |
Gpr139 |
G protein-coupled receptor 139 |
202 |
0.96 |
chr2_57378572_57378776 | 5.22 |
Gm13531 |
predicted gene 13531 |
47035 |
0.16 |
chr1_70725543_70726581 | 5.20 |
Vwc2l |
von Willebrand factor C domain-containing protein 2-like |
139 |
0.98 |
chr7_19851812_19852890 | 5.19 |
Gm19345 |
predicted gene, 19345 |
348 |
0.7 |
chr7_135410284_135411329 | 5.18 |
Foxi2 |
forkhead box I2 |
439 |
0.84 |
chr1_9658942_9659284 | 5.16 |
Gm29520 |
predicted gene 29520 |
18531 |
0.13 |
chr7_101422402_101423202 | 5.16 |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
956 |
0.45 |
chr2_179787105_179787624 | 5.16 |
Cdh4 |
cadherin 4 |
10201 |
0.27 |
chr2_162661151_162661382 | 5.12 |
9430021M05Rik |
RIKEN cDNA 9430021M05 gene |
103 |
0.52 |
chr4_55928799_55929534 | 5.12 |
Gm12519 |
predicted gene 12519 |
64573 |
0.14 |
chr1_63540022_63540421 | 5.09 |
Adam23 |
a disintegrin and metallopeptidase domain 23 |
3254 |
0.26 |
chr8_109311337_109312145 | 5.08 |
Gm1943 |
predicted gene 1943 |
29123 |
0.2 |
chr7_105569902_105570152 | 5.08 |
Apbb1 |
amyloid beta (A4) precursor protein-binding, family B, member 1 |
435 |
0.71 |
chr2_52511844_52512426 | 5.04 |
Gm13541 |
predicted gene 13541 |
39834 |
0.14 |
chr10_60108443_60108682 | 5.00 |
Spock2 |
sparc/osteonectin, cwcv and kazal-like domains proteoglycan 2 |
2094 |
0.32 |
chr18_62324201_62324630 | 4.98 |
Htr4 |
5 hydroxytryptamine (serotonin) receptor 4 |
211 |
0.96 |
chr1_88669139_88669535 | 4.96 |
Gm29336 |
predicted gene 29336 |
13029 |
0.15 |
chr2_66439804_66441087 | 4.91 |
Scn1a |
sodium channel, voltage-gated, type I, alpha |
369 |
0.52 |
chr19_59462586_59463447 | 4.88 |
Emx2 |
empty spiracles homeobox 2 |
214 |
0.92 |
chr7_25174199_25174655 | 4.88 |
Pou2f2 |
POU domain, class 2, transcription factor 2 |
5299 |
0.11 |
chr17_31386282_31387332 | 4.86 |
Pde9a |
phosphodiesterase 9A |
513 |
0.74 |
chr11_82508511_82509165 | 4.85 |
Tmem132e |
transmembrane protein 132E |
70581 |
0.09 |
chr7_4546391_4547839 | 4.82 |
Syt5 |
synaptotagmin V |
142 |
0.89 |
chr19_59463596_59464359 | 4.80 |
Emx2 |
empty spiracles homeobox 2 |
1175 |
0.44 |
chr10_104455824_104456122 | 4.79 |
Gm22945 |
predicted gene, 22945 |
15234 |
0.27 |
chr3_152979582_152980188 | 4.78 |
St6galnac5 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
2167 |
0.29 |
chr9_121303635_121304138 | 4.77 |
Trak1 |
trafficking protein, kinesin binding 1 |
6057 |
0.15 |
chr5_77058285_77058946 | 4.69 |
Thegl |
theg spermatid protein like |
21561 |
0.11 |
chr1_42539071_42540720 | 4.69 |
Gm37047 |
predicted gene, 37047 |
48082 |
0.15 |
chr14_63585801_63587038 | 4.67 |
Xkr6 |
X-linked Kx blood group related 6 |
20084 |
0.15 |
chr7_62416059_62417205 | 4.67 |
Mkrn3 |
makorin, ring finger protein, 3 |
3507 |
0.2 |
chr12_119235052_119235331 | 4.66 |
Itgb8 |
integrin beta 8 |
3579 |
0.28 |
chr9_117871858_117873400 | 4.64 |
Rbms3 |
RNA binding motif, single stranded interacting protein |
45 |
0.91 |
chr15_99669994_99670214 | 4.64 |
Asic1 |
acid-sensing (proton-gated) ion channel 1 |
264 |
0.82 |
chr1_35869391_35870207 | 4.61 |
1110002O04Rik |
RIKEN cDNA 1110002O04 gene |
10046 |
0.21 |
chr7_122477830_122478098 | 4.58 |
Gm14389 |
predicted gene 14389 |
6456 |
0.17 |
chr1_177446374_177448525 | 4.54 |
Zbtb18 |
zinc finger and BTB domain containing 18 |
1628 |
0.31 |
chr6_122741558_122742751 | 4.53 |
Slc2a3 |
solute carrier family 2 (facilitated glucose transporter), member 3 |
108 |
0.95 |
chr13_100892366_100893024 | 4.52 |
Gm41041 |
predicted gene, 41041 |
17194 |
0.14 |
chr17_43952337_43954220 | 4.52 |
Rcan2 |
regulator of calcineurin 2 |
27 |
0.99 |
chr4_35844509_35845617 | 4.51 |
Lingo2 |
leucine rich repeat and Ig domain containing 2 |
141 |
0.98 |
chr1_79438692_79439000 | 4.49 |
Scg2 |
secretogranin II |
1196 |
0.57 |
chr8_83591037_83591339 | 4.47 |
Tecr |
trans-2,3-enoyl-CoA reductase |
3233 |
0.12 |
chr11_16257036_16258354 | 4.47 |
Vstm2a |
V-set and transmembrane domain containing 2A |
29 |
0.98 |
chr2_94246278_94247531 | 4.45 |
Mir670hg |
MIR670 host gene (non-protein coding) |
3566 |
0.17 |
chrX_136290697_136291204 | 4.44 |
n-R5s12 |
nuclear encoded rRNA 5S 12 |
13445 |
0.09 |
chr9_91372507_91373295 | 4.43 |
Zic4 |
zinc finger protein of the cerebellum 4 |
1551 |
0.25 |
chr15_76519928_76521866 | 4.42 |
Scrt1 |
scratch family zinc finger 1 |
1005 |
0.28 |
chr3_28264634_28265464 | 4.41 |
Tnik |
TRAF2 and NCK interacting kinase |
1406 |
0.45 |
chr13_81629335_81629499 | 4.40 |
Adgrv1 |
adhesion G protein-coupled receptor V1 |
3722 |
0.24 |
chr3_152980951_152982389 | 4.39 |
St6galnac5 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 |
382 |
0.86 |
chr9_41326803_41329121 | 4.39 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
676 |
0.69 |
chr13_110280269_110281178 | 4.36 |
Rab3c |
RAB3C, member RAS oncogene family |
178 |
0.96 |
chr1_25892431_25892633 | 4.34 |
Gm9884 |
predicted gene 9884 |
61875 |
0.08 |
chr1_65311039_65312195 | 4.34 |
Pth2r |
parathyroid hormone 2 receptor |
360 |
0.89 |
chr17_85393481_85393696 | 4.33 |
Rpl31-ps16 |
ribosomal protein L31, pseudogene 16 |
105045 |
0.07 |
chr6_145048452_145048971 | 4.27 |
Bcat1 |
branched chain aminotransferase 1, cytosolic |
101 |
0.93 |
chr8_40187126_40187473 | 4.27 |
Fgf20 |
fibroblast growth factor 20 |
99654 |
0.07 |
chr11_101176105_101177957 | 4.26 |
Cntnap1 |
contactin associated protein-like 1 |
990 |
0.28 |
chr8_89036575_89038609 | 4.26 |
Sall1 |
spalt like transcription factor 1 |
6570 |
0.23 |
chr2_94245067_94246249 | 4.19 |
Mir670hg |
MIR670 host gene (non-protein coding) |
2320 |
0.21 |
chr1_76637121_76637710 | 4.19 |
Mir6343 |
microRNA 6343 |
127855 |
0.06 |
chr12_15218582_15218786 | 4.18 |
Gm48539 |
predicted gene, 48539 |
82361 |
0.09 |
chr4_116405618_116406369 | 4.16 |
Mast2 |
microtubule associated serine/threonine kinase 2 |
7 |
0.98 |
chr9_107403033_107403196 | 4.15 |
Cacna2d2 |
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
3045 |
0.16 |
chrX_96712746_96713886 | 4.15 |
Gpr165 |
G protein-coupled receptor 165 |
125 |
0.98 |
chr6_138420997_138421670 | 4.15 |
Lmo3 |
LIM domain only 3 |
119 |
0.96 |
chr11_107979839_107979990 | 4.13 |
Prkca |
protein kinase C, alpha |
275 |
0.89 |
chr5_113492294_113493538 | 4.13 |
Wscd2 |
WSC domain containing 2 |
2164 |
0.36 |
chr9_72812558_72813462 | 4.09 |
Prtg |
protogenin |
6136 |
0.13 |
chr10_57784547_57786586 | 4.07 |
Fabp7 |
fatty acid binding protein 7, brain |
643 |
0.68 |
chr1_159523756_159524611 | 4.07 |
Tnr |
tenascin R |
342 |
0.91 |
chr1_172200944_172201673 | 4.06 |
Pea15a |
phosphoprotein enriched in astrocytes 15A |
1493 |
0.23 |
chr12_80759551_80760722 | 4.03 |
Ccdc177 |
coiled-coil domain containing 177 |
551 |
0.62 |
chr7_115823042_115823788 | 4.02 |
Sox6 |
SRY (sex determining region Y)-box 6 |
1295 |
0.6 |
chr2_97470615_97471412 | 4.01 |
Lrrc4c |
leucine rich repeat containing 4C |
2924 |
0.4 |
chr2_83758891_83759726 | 3.99 |
Gm13684 |
predicted gene 13684 |
557 |
0.73 |
chr18_43390784_43391261 | 3.95 |
Dpysl3 |
dihydropyrimidinase-like 3 |
2355 |
0.34 |
chr10_6788358_6789268 | 3.95 |
Oprm1 |
opioid receptor, mu 1 |
4 |
0.99 |
chr3_154663659_154664932 | 3.94 |
Erich3 |
glutamate rich 3 |
436 |
0.82 |
chrX_153038435_153038689 | 3.93 |
9530051G07Rik |
RIKEN cDNA 9530051G07 gene |
933 |
0.37 |
chr13_94880143_94880510 | 3.93 |
Otp |
orthopedia homeobox |
2274 |
0.32 |
chr13_48259532_48259998 | 3.92 |
Id4 |
inhibitor of DNA binding 4 |
1463 |
0.28 |
chr1_38439659_38440010 | 3.91 |
Gm34727 |
predicted gene, 34727 |
47685 |
0.14 |
chr14_101378990_101379549 | 3.88 |
Hspd1-ps5 |
heat shock protein 1 (chaperonin), pseudogene 5 |
35725 |
0.19 |
chr7_54835204_54836499 | 3.87 |
Luzp2 |
leucine zipper protein 2 |
236 |
0.94 |
chr5_90902965_90904167 | 3.86 |
Cxcl2 |
chemokine (C-X-C motif) ligand 2 |
305 |
0.84 |
chr9_72533965_72534704 | 3.86 |
Rfx7 |
regulatory factor X, 7 |
1599 |
0.21 |
chr7_79507974_79509311 | 3.85 |
A330074H02Rik |
RIKEN cDNA A330074H02 gene |
1720 |
0.18 |
chr13_55483242_55484428 | 3.85 |
Dbn1 |
drebrin 1 |
134 |
0.9 |
chrX_165325643_165325925 | 3.84 |
Glra2 |
glycine receptor, alpha 2 subunit |
1609 |
0.56 |
chr14_122280336_122281519 | 3.84 |
Clybl |
citrate lyase beta like |
22886 |
0.18 |
chr13_83724063_83724214 | 3.82 |
C130071C03Rik |
RIKEN cDNA C130071C03 gene |
2757 |
0.18 |
chr4_72382466_72383150 | 3.81 |
Gm11235 |
predicted gene 11235 |
159858 |
0.04 |
chr4_135833601_135833752 | 3.81 |
Gm13000 |
predicted gene 13000 |
20002 |
0.1 |
chr10_101682665_101683088 | 3.81 |
Mgat4c |
MGAT4 family, member C |
1130 |
0.6 |
chr10_58817039_58817233 | 3.80 |
Sh3rf3 |
SH3 domain containing ring finger 3 |
3077 |
0.24 |
chrX_134407085_134407371 | 3.78 |
Drp2 |
dystrophin related protein 2 |
2426 |
0.27 |
chr3_97763340_97765161 | 3.78 |
Pde4dip |
phosphodiesterase 4D interacting protein (myomegalin) |
3681 |
0.23 |
chr7_126277403_126277977 | 3.78 |
Sbk1 |
SH3-binding kinase 1 |
4290 |
0.14 |
chr15_90820047_90820242 | 3.78 |
Rpl31-ps8 |
ribosomal protein L31, pseudogene 8 |
55488 |
0.1 |
chr6_55676662_55677830 | 3.76 |
Neurod6 |
neurogenic differentiation 6 |
4017 |
0.26 |
chr6_104492794_104494036 | 3.74 |
Cntn6 |
contactin 6 |
167 |
0.98 |
chr8_32883592_32884962 | 3.72 |
Nrg1 |
neuregulin 1 |
23 |
0.99 |
chr1_78167977_78168256 | 3.72 |
Pax3 |
paired box 3 |
28722 |
0.2 |
chrX_158923078_158924649 | 3.71 |
Gm5764 |
predicted gene 5764 |
90428 |
0.09 |
chr7_62365207_62365438 | 3.71 |
Magel2 |
melanoma antigen, family L, 2 |
11688 |
0.17 |
chr8_122335750_122336915 | 3.70 |
Zfpm1 |
zinc finger protein, multitype 1 |
1701 |
0.24 |
chr18_57468245_57468987 | 3.69 |
Ctxn3 |
cortexin 3 |
94 |
0.97 |
chr7_79496540_79498275 | 3.68 |
Mir9-3hg |
Mir9-3 host gene |
2619 |
0.13 |
chr18_20609699_20610303 | 3.68 |
Dsg2 |
desmoglein 2 |
51755 |
0.1 |
chr2_51066540_51066855 | 3.67 |
Rnd3 |
Rho family GTPase 3 |
82397 |
0.1 |
chr5_26904124_26905425 | 3.67 |
Dpp6 |
dipeptidylpeptidase 6 |
79 |
0.98 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.0 | 6.1 | GO:0046684 | response to pyrethroid(GO:0046684) |
1.5 | 4.4 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.3 | 9.4 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
1.3 | 4.0 | GO:0061355 | Wnt protein secretion(GO:0061355) regulation of Wnt protein secretion(GO:0061356) |
1.3 | 3.9 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
1.3 | 3.9 | GO:0048682 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
1.2 | 13.6 | GO:0097120 | receptor localization to synapse(GO:0097120) |
1.2 | 3.7 | GO:0009449 | gamma-aminobutyric acid biosynthetic process(GO:0009449) |
1.2 | 4.9 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.2 | 6.1 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
1.2 | 4.8 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
1.2 | 9.5 | GO:0046069 | cGMP catabolic process(GO:0046069) |
1.1 | 3.4 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.1 | 1.1 | GO:0072309 | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis(GO:0072309) |
1.1 | 5.4 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
1.1 | 8.5 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
1.1 | 4.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
1.0 | 4.2 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
1.0 | 3.1 | GO:0033563 | dorsal/ventral axon guidance(GO:0033563) |
1.0 | 5.1 | GO:0021779 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
1.0 | 10.2 | GO:0071625 | vocalization behavior(GO:0071625) |
1.0 | 3.0 | GO:0072221 | distal convoluted tubule development(GO:0072025) DCT cell differentiation(GO:0072069) metanephric distal convoluted tubule development(GO:0072221) metanephric distal tubule development(GO:0072235) metanephric DCT cell differentiation(GO:0072240) |
1.0 | 2.0 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
1.0 | 4.0 | GO:0006551 | leucine metabolic process(GO:0006551) |
1.0 | 3.0 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
1.0 | 2.9 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
1.0 | 2.9 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.9 | 2.8 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.9 | 13.8 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.9 | 6.4 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.9 | 5.4 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.9 | 2.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.9 | 2.7 | GO:0072017 | distal tubule development(GO:0072017) |
0.9 | 1.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.8 | 3.3 | GO:0001994 | norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure(GO:0001994) |
0.8 | 2.4 | GO:1901536 | regulation of DNA demethylation(GO:1901535) negative regulation of DNA demethylation(GO:1901536) |
0.8 | 1.6 | GO:0060594 | mammary gland specification(GO:0060594) |
0.8 | 1.6 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
0.8 | 3.9 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.8 | 3.1 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
0.8 | 12.2 | GO:0021952 | central nervous system projection neuron axonogenesis(GO:0021952) |
0.7 | 3.0 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.7 | 4.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.7 | 5.8 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
0.7 | 2.8 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.7 | 2.7 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.7 | 6.7 | GO:0007210 | serotonin receptor signaling pathway(GO:0007210) |
0.7 | 3.3 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.7 | 2.6 | GO:0070093 | negative regulation of glucagon secretion(GO:0070093) |
0.6 | 1.9 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.6 | 1.9 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.6 | 2.5 | GO:0035106 | operant conditioning(GO:0035106) |
0.6 | 4.2 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.6 | 7.8 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.6 | 8.2 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.6 | 2.9 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.6 | 2.3 | GO:0090135 | actin filament branching(GO:0090135) |
0.6 | 4.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.6 | 2.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.5 | 1.1 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.5 | 4.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.5 | 3.2 | GO:0051823 | regulation of synapse structural plasticity(GO:0051823) |
0.5 | 1.1 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
0.5 | 0.5 | GO:0071504 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) |
0.5 | 0.5 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
0.5 | 1.5 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.5 | 5.1 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.5 | 3.0 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.5 | 0.5 | GO:0061642 | chemoattraction of axon(GO:0061642) |
0.5 | 3.0 | GO:0015884 | folic acid transport(GO:0015884) |
0.5 | 1.5 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.5 | 8.4 | GO:0071475 | cellular hyperosmotic salinity response(GO:0071475) |
0.5 | 0.5 | GO:1902913 | positive regulation of neuroepithelial cell differentiation(GO:1902913) |
0.5 | 1.0 | GO:0015888 | thiamine transport(GO:0015888) |
0.5 | 0.5 | GO:0021550 | medulla oblongata development(GO:0021550) |
0.5 | 0.5 | GO:0003402 | planar cell polarity pathway involved in axis elongation(GO:0003402) |
0.5 | 3.8 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.5 | 2.3 | GO:1903273 | regulation of sodium ion export(GO:1903273) regulation of sodium ion export from cell(GO:1903276) |
0.5 | 1.4 | GO:0021747 | cochlear nucleus development(GO:0021747) |
0.5 | 1.4 | GO:2000807 | regulation of synaptic vesicle clustering(GO:2000807) |
0.4 | 0.9 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.4 | 1.3 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.4 | 1.3 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
0.4 | 0.4 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
0.4 | 4.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.4 | 1.3 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.4 | 1.3 | GO:0007525 | somatic muscle development(GO:0007525) |
0.4 | 0.8 | GO:0032730 | positive regulation of interleukin-1 alpha production(GO:0032730) |
0.4 | 1.2 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.4 | 6.0 | GO:0021854 | hypothalamus development(GO:0021854) |
0.4 | 4.0 | GO:0071435 | potassium ion export(GO:0071435) |
0.4 | 0.8 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
0.4 | 3.5 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.4 | 2.7 | GO:0042436 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.4 | 3.1 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.4 | 1.9 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.4 | 1.1 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 1.5 | GO:0021955 | central nervous system neuron axonogenesis(GO:0021955) |
0.4 | 2.2 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.4 | 2.2 | GO:0035280 | miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) |
0.4 | 1.1 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.4 | 1.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.4 | 1.1 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.4 | 3.6 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.4 | 1.1 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
0.4 | 1.1 | GO:2000041 | regulation of planar cell polarity pathway involved in axis elongation(GO:2000040) negative regulation of planar cell polarity pathway involved in axis elongation(GO:2000041) |
0.4 | 2.8 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.4 | 0.4 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.4 | 0.7 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.3 | 1.0 | GO:0046668 | regulation of retinal cell programmed cell death(GO:0046668) |
0.3 | 1.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 1.0 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 0.3 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.3 | 4.7 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.3 | 1.0 | GO:0033602 | negative regulation of dopamine secretion(GO:0033602) |
0.3 | 2.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.3 | 1.3 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
0.3 | 1.3 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.3 | 0.3 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.3 | 1.0 | GO:0060120 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.3 | 3.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.3 | 1.0 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
0.3 | 3.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.3 | 1.0 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.3 | 6.1 | GO:0048488 | synaptic vesicle endocytosis(GO:0048488) |
0.3 | 1.0 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.3 | 8.9 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.3 | 1.9 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.3 | 0.6 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.3 | 0.6 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.3 | 0.9 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.3 | 1.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.3 | 0.6 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.3 | 1.8 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.3 | 1.5 | GO:0014028 | notochord formation(GO:0014028) |
0.3 | 10.8 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.3 | 0.9 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.3 | 0.6 | GO:0060174 | limb bud formation(GO:0060174) |
0.3 | 1.4 | GO:2000310 | regulation of N-methyl-D-aspartate selective glutamate receptor activity(GO:2000310) |
0.3 | 2.8 | GO:0035640 | exploration behavior(GO:0035640) |
0.3 | 2.5 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.3 | 0.8 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.3 | 0.5 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.3 | 0.5 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.3 | 0.8 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.3 | 3.2 | GO:0032310 | prostaglandin secretion(GO:0032310) |
0.3 | 2.1 | GO:0090177 | establishment of planar polarity involved in neural tube closure(GO:0090177) |
0.3 | 0.5 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.3 | 0.5 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.3 | 0.3 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.3 | 0.3 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
0.3 | 2.0 | GO:0090128 | regulation of synapse maturation(GO:0090128) positive regulation of synapse maturation(GO:0090129) |
0.3 | 1.0 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.3 | 0.8 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.2 | 1.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.2 | 0.7 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 1.2 | GO:0032596 | protein transport into membrane raft(GO:0032596) |
0.2 | 1.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.2 | 1.0 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 2.0 | GO:0021895 | cerebral cortex neuron differentiation(GO:0021895) |
0.2 | 1.0 | GO:0034047 | regulation of protein phosphatase type 2A activity(GO:0034047) |
0.2 | 1.2 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
0.2 | 1.2 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 1.0 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 3.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.2 | 0.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.2 | 2.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.2 | 0.7 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.2 | 0.7 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.2 | 0.7 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 2.5 | GO:0001964 | startle response(GO:0001964) |
0.2 | 0.5 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
0.2 | 2.5 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.2 | 1.1 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.2 | 0.4 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.2 | 0.2 | GO:0021776 | smoothened signaling pathway involved in ventral spinal cord interneuron specification(GO:0021775) smoothened signaling pathway involved in spinal cord motor neuron cell fate specification(GO:0021776) |
0.2 | 0.9 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.2 | 0.9 | GO:0051968 | positive regulation of synaptic transmission, glutamatergic(GO:0051968) |
0.2 | 1.5 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.2 | 0.6 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.2 | 2.2 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.2 | 0.4 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.2 | 0.6 | GO:0010288 | response to lead ion(GO:0010288) |
0.2 | 2.3 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 1.7 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.2 | 1.3 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.2 | 0.4 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.2 | 16.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.2 | 0.8 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.2 | 0.2 | GO:0036515 | serotonergic neuron axon guidance(GO:0036515) |
0.2 | 0.6 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.2 | 0.8 | GO:0021794 | thalamus development(GO:0021794) |
0.2 | 0.4 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.8 | GO:0006041 | glucosamine metabolic process(GO:0006041) |
0.2 | 1.6 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.8 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.2 | 0.2 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 2.8 | GO:0002347 | response to tumor cell(GO:0002347) |
0.2 | 7.0 | GO:0008542 | visual learning(GO:0008542) |
0.2 | 0.6 | GO:0002525 | acute inflammatory response to non-antigenic stimulus(GO:0002525) |
0.2 | 1.2 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.2 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.2 | 1.4 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.2 | 0.2 | GO:0072038 | mesenchymal stem cell maintenance involved in nephron morphogenesis(GO:0072038) |
0.2 | 3.9 | GO:0050802 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) circadian sleep/wake cycle, sleep(GO:0050802) |
0.2 | 3.9 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.2 | 1.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.2 | 0.6 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 0.8 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.2 | 1.7 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.2 | 0.6 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.2 | 1.9 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.2 | 0.6 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.2 | 0.4 | GO:0014722 | regulation of skeletal muscle contraction by calcium ion signaling(GO:0014722) |
0.2 | 0.2 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.2 | 2.6 | GO:1901381 | positive regulation of potassium ion transmembrane transport(GO:1901381) |
0.2 | 0.7 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.7 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.2 | 0.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.2 | 1.8 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.5 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
0.2 | 5.7 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.2 | 0.9 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.3 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.2 | 0.7 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) |
0.2 | 0.8 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.2 | 1.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.7 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.3 | GO:0070782 | phosphatidylserine exposure on apoptotic cell surface(GO:0070782) |
0.2 | 1.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.2 | 1.3 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.2 | 0.6 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
0.2 | 0.5 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.2 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.2 | 0.5 | GO:0015755 | fructose transport(GO:0015755) |
0.2 | 0.6 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.8 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.2 | 0.5 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.2 | 0.6 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 0.8 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 2.2 | GO:0032011 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 0.1 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.1 | 0.4 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.1 | 0.1 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
0.1 | 0.4 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.4 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 5.9 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.1 | 0.6 | GO:0022038 | corpus callosum development(GO:0022038) |
0.1 | 0.4 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.1 | 0.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.6 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 1.3 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.1 | 0.7 | GO:1902969 | mitotic DNA replication(GO:1902969) |
0.1 | 0.6 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.1 | 0.3 | GO:0042851 | alanine metabolic process(GO:0006522) pyruvate family amino acid metabolic process(GO:0009078) L-alanine metabolic process(GO:0042851) |
0.1 | 0.6 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.1 | 1.0 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.1 | 0.5 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.3 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.8 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.1 | 0.9 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.1 | 0.5 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
0.1 | 0.8 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.1 | 0.1 | GO:0072034 | renal vesicle induction(GO:0072034) |
0.1 | 0.7 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.1 | 1.8 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.1 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.1 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle transport(GO:1902804) negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.1 | GO:0001956 | positive regulation of neurotransmitter secretion(GO:0001956) |
0.1 | 1.9 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.1 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.1 | 0.6 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.1 | 0.4 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.1 | 0.4 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.1 | 0.5 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 1.1 | GO:0006828 | manganese ion transport(GO:0006828) |
0.1 | 0.4 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.6 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.1 | 1.5 | GO:0010738 | regulation of protein kinase A signaling(GO:0010738) |
0.1 | 1.5 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.1 | 0.7 | GO:1904321 | response to forskolin(GO:1904321) cellular response to forskolin(GO:1904322) |
0.1 | 1.2 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 2.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.4 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.1 | 0.2 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
0.1 | 0.8 | GO:1900107 | regulation of nodal signaling pathway(GO:1900107) |
0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.1 | 0.2 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
0.1 | 0.4 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.1 | 0.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.6 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.7 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.1 | 0.3 | GO:0040031 | snRNA modification(GO:0040031) |
0.1 | 0.7 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.1 | 0.1 | GO:0033153 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.1 | 0.3 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
0.1 | 0.3 | GO:0046881 | positive regulation of follicle-stimulating hormone secretion(GO:0046881) |
0.1 | 0.4 | GO:0021670 | lateral ventricle development(GO:0021670) |
0.1 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.1 | 0.1 | GO:0032907 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
0.1 | 1.1 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.1 | 0.1 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.1 | 0.3 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.1 | 0.1 | GO:0032762 | mast cell cytokine production(GO:0032762) |
0.1 | 0.5 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.1 | 0.3 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.1 | 0.1 | GO:0061205 | paramesonephric duct development(GO:0061205) |
0.1 | 0.1 | GO:2000171 | negative regulation of dendrite development(GO:2000171) |
0.1 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.3 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.2 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
0.1 | 8.0 | GO:0050684 | regulation of mRNA processing(GO:0050684) |
0.1 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.1 | 2.5 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
0.1 | 2.7 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 0.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.5 | GO:0046146 | tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 0.3 | GO:0036233 | glycine import(GO:0036233) |
0.1 | 0.1 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.1 | 0.3 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.1 | GO:1903898 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) |
0.1 | 0.3 | GO:0015886 | heme transport(GO:0015886) |
0.1 | 1.0 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
0.1 | 0.2 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.1 | 0.2 | GO:0032055 | negative regulation of translation in response to stress(GO:0032055) |
0.1 | 0.1 | GO:0048934 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.3 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.6 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
0.1 | 0.3 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) spinal cord motor neuron migration(GO:0097476) |
0.1 | 7.8 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.1 | 0.6 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.1 | 0.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
0.1 | 0.1 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.2 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.3 | GO:0035964 | COPI-coated vesicle budding(GO:0035964) |
0.1 | 0.2 | GO:0072077 | renal vesicle morphogenesis(GO:0072077) |
0.1 | 0.3 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.1 | 1.6 | GO:0045687 | positive regulation of glial cell differentiation(GO:0045687) |
0.1 | 1.7 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.1 | 0.4 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.3 | GO:0002087 | regulation of respiratory gaseous exchange by neurological system process(GO:0002087) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.2 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.1 | 0.1 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.1 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.1 | 2.4 | GO:0034394 | protein localization to cell surface(GO:0034394) |
0.1 | 0.5 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 0.2 | GO:0001975 | response to amphetamine(GO:0001975) |
0.1 | 0.2 | GO:0014010 | Schwann cell proliferation(GO:0014010) |
0.1 | 0.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
0.1 | 0.2 | GO:0006680 | glucosylceramide catabolic process(GO:0006680) |
0.1 | 0.3 | GO:1904526 | regulation of microtubule binding(GO:1904526) positive regulation of microtubule binding(GO:1904528) |
0.1 | 0.4 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.5 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.1 | 0.3 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.1 | 0.7 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.1 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.3 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.3 | GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002924) |
0.1 | 0.1 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.1 | 0.7 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.1 | 0.1 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.1 | 0.3 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.1 | 2.7 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.1 | 3.2 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.6 | GO:0032604 | granulocyte macrophage colony-stimulating factor production(GO:0032604) regulation of granulocyte macrophage colony-stimulating factor production(GO:0032645) |
0.1 | 0.3 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.3 | GO:0001504 | neurotransmitter uptake(GO:0001504) |
0.1 | 1.0 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
0.1 | 0.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.1 | 0.9 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.1 | 0.6 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.1 | 0.1 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.1 | GO:0033483 | gas homeostasis(GO:0033483) negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.1 | 0.4 | GO:1904666 | regulation of ubiquitin protein ligase activity(GO:1904666) |
0.1 | 0.2 | GO:0075136 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.1 | GO:0044027 | DNA hypermethylation(GO:0044026) hypermethylation of CpG island(GO:0044027) |
0.1 | 1.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.1 | 0.7 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.1 | 0.1 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.1 | 0.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
0.1 | 0.6 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.6 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 4.3 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.1 | 0.2 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.1 | 0.2 | GO:0015746 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
0.1 | 0.2 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.1 | 0.8 | GO:0097320 | membrane tubulation(GO:0097320) |
0.1 | 3.8 | GO:0007200 | phospholipase C-activating G-protein coupled receptor signaling pathway(GO:0007200) |
0.1 | 0.3 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.1 | 0.5 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.2 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.1 | 2.0 | GO:0034314 | Arp2/3 complex-mediated actin nucleation(GO:0034314) |
0.1 | 1.1 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.5 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.1 | 0.9 | GO:0060997 | dendritic spine morphogenesis(GO:0060997) |
0.1 | 0.2 | GO:2000510 | positive regulation of dendritic cell chemotaxis(GO:2000510) |
0.1 | 0.5 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 0.1 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.1 | GO:0098739 | import across plasma membrane(GO:0098739) |
0.1 | 0.2 | GO:0072718 | response to cisplatin(GO:0072718) |
0.1 | 0.1 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
0.1 | 0.1 | GO:0019062 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.1 | 0.1 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.1 | 0.2 | GO:0032439 | endosome localization(GO:0032439) |
0.1 | 0.8 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 0.2 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.1 | 0.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.1 | 0.1 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
0.1 | 0.4 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.1 | 0.6 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.3 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
0.1 | 0.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.1 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.2 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.1 | 0.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.1 | 0.3 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.1 | 0.1 | GO:0097466 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
0.1 | 0.3 | GO:0031339 | negative regulation of vesicle fusion(GO:0031339) |
0.1 | 0.1 | GO:0089700 | protein kinase D signaling(GO:0089700) |
0.1 | 0.2 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.1 | 0.3 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.5 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.1 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.1 | 0.1 | GO:0071873 | response to norepinephrine(GO:0071873) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.2 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.1 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.1 | 2.8 | GO:0048813 | dendrite morphogenesis(GO:0048813) |
0.1 | 0.1 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.1 | 1.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 1.4 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.3 | GO:0002634 | regulation of germinal center formation(GO:0002634) positive regulation of germinal center formation(GO:0002636) |
0.1 | 0.2 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.1 | 0.2 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.1 | GO:0071947 | protein K29-linked deubiquitination(GO:0035523) protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.9 | GO:0035249 | synaptic transmission, glutamatergic(GO:0035249) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 0.2 | GO:0086014 | atrial cardiac muscle cell action potential(GO:0086014) atrial cardiac muscle cell to AV node cell signaling(GO:0086026) atrial cardiac muscle cell to AV node cell communication(GO:0086066) |
0.1 | 1.6 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.1 | 0.4 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
0.1 | 0.1 | GO:0002884 | negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0051938 | L-glutamate import(GO:0051938) |
0.1 | 0.1 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
0.1 | 0.1 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.1 | 0.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 1.0 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.6 | GO:0021766 | hippocampus development(GO:0021766) |
0.1 | 0.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.1 | 0.5 | GO:0035176 | social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
0.1 | 0.3 | GO:0021885 | forebrain cell migration(GO:0021885) |
0.1 | 2.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.6 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.1 | 5.0 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.1 | 0.2 | GO:0030431 | sleep(GO:0030431) |
0.1 | 0.2 | GO:0035624 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 0.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.1 | 0.1 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.1 | 0.1 | GO:1901679 | nucleotide transmembrane transport(GO:1901679) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.1 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
0.1 | 0.2 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 0.2 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.1 | 0.1 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.2 | GO:0007567 | parturition(GO:0007567) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.2 | GO:0006598 | polyamine catabolic process(GO:0006598) |
0.1 | 0.2 | GO:0051181 | cofactor transport(GO:0051181) |
0.1 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
0.1 | 0.2 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.1 | 0.2 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) |
0.1 | 0.4 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.2 | GO:2000348 | regulation of CD40 signaling pathway(GO:2000348) |
0.1 | 0.1 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.1 | 0.1 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 0.1 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.1 | 0.2 | GO:1901028 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901028) |
0.1 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.1 | 0.9 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
0.1 | 0.6 | GO:0044550 | secondary metabolite biosynthetic process(GO:0044550) |
0.1 | 0.1 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
0.1 | 0.2 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.1 | 0.4 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.1 | 0.1 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.0 | 0.2 | GO:0033313 | meiotic cell cycle checkpoint(GO:0033313) |
0.0 | 0.2 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
0.0 | 1.3 | GO:0050808 | synapse organization(GO:0050808) |
0.0 | 0.1 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.0 | 0.2 | GO:0021535 | cell migration in hindbrain(GO:0021535) |
0.0 | 0.1 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.0 | 0.1 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.0 | 0.9 | GO:0046579 | positive regulation of Ras protein signal transduction(GO:0046579) |
0.0 | 0.0 | GO:0032971 | regulation of muscle filament sliding(GO:0032971) |
0.0 | 0.0 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.0 | 0.2 | GO:0098815 | modulation of excitatory postsynaptic potential(GO:0098815) |
0.0 | 0.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.0 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.0 | 0.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.0 | 0.0 | GO:1903044 | protein localization to membrane raft(GO:1903044) |
0.0 | 0.0 | GO:0002432 | granuloma formation(GO:0002432) |
0.0 | 0.1 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
0.0 | 0.0 | GO:0010825 | positive regulation of centrosome duplication(GO:0010825) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.2 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.0 | 0.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.0 | 0.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.0 | 0.1 | GO:0090290 | positive regulation of osteoclast proliferation(GO:0090290) |
0.0 | 0.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.0 | 0.1 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
0.0 | 0.0 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.0 | 0.1 | GO:0061308 | cardiac neural crest cell development involved in heart development(GO:0061308) |
0.0 | 0.3 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0031049 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:0036490 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.0 | 0.1 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.0 | 0.3 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
0.0 | 0.4 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.0 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.0 | 0.1 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.0 | 0.1 | GO:1904415 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.0 | 0.2 | GO:0035418 | protein localization to synapse(GO:0035418) |
0.0 | 0.8 | GO:0042073 | intraciliary transport(GO:0042073) |
0.0 | 0.1 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.0 | 0.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.3 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.0 | 0.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.0 | 0.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.4 | GO:0003351 | epithelial cilium movement(GO:0003351) |
0.0 | 0.0 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.0 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.0 | 0.4 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0072053 | renal inner medulla development(GO:0072053) |
0.0 | 0.0 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.0 | 0.1 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.0 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.0 | 0.0 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.0 | 0.5 | GO:0034122 | negative regulation of toll-like receptor signaling pathway(GO:0034122) |
0.0 | 1.6 | GO:0099531 | presynaptic process involved in chemical synaptic transmission(GO:0099531) |
0.0 | 0.8 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.2 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.2 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
0.0 | 0.1 | GO:0046174 | polyol catabolic process(GO:0046174) |
0.0 | 0.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.0 | 0.3 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.0 | 0.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.0 | 0.2 | GO:0043576 | regulation of respiratory gaseous exchange(GO:0043576) |
0.0 | 0.1 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.0 | 0.1 | GO:0021593 | rhombomere morphogenesis(GO:0021593) |
0.0 | 0.0 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.0 | 0.2 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.0 | 0.8 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.0 | 0.0 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.0 | 0.1 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.0 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 0.1 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
0.0 | 0.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.0 | 0.6 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.4 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.0 | 0.4 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.0 | 0.0 | GO:0016068 | regulation of type I hypersensitivity(GO:0001810) positive regulation of type I hypersensitivity(GO:0001812) type I hypersensitivity(GO:0016068) |
0.0 | 0.1 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.0 | 0.3 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.8 | GO:0046785 | microtubule polymerization(GO:0046785) |
0.0 | 0.1 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.1 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.0 | 0.1 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.0 | 0.2 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.2 | GO:1903831 | acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
0.0 | 0.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.2 | GO:0036315 | cellular response to sterol(GO:0036315) |
0.0 | 0.0 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.0 | 0.1 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.0 | 0.4 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.0 | 0.0 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.3 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.0 | 0.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.0 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0034628 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 0.0 | GO:0015819 | lysine transport(GO:0015819) |
0.0 | 0.1 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
0.0 | 0.1 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.0 | 0.1 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.0 | 0.3 | GO:0003334 | keratinocyte development(GO:0003334) |
0.0 | 0.2 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.0 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.1 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
0.0 | 0.3 | GO:0046847 | filopodium assembly(GO:0046847) |
0.0 | 0.0 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.0 | 0.1 | GO:0070268 | cornification(GO:0070268) |
0.0 | 1.8 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.0 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
0.0 | 0.1 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.0 | 0.2 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.0 | 0.1 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.0 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 0.2 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.1 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.1 | GO:0060662 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.0 | 0.2 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.0 | GO:0072553 | terminal button organization(GO:0072553) |
0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.1 | GO:0032826 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
0.0 | 0.2 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.0 | 0.1 | GO:0042939 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
0.0 | 0.2 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.0 | GO:0070948 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.0 | 0.4 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.0 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:1902692 | regulation of neuroblast proliferation(GO:1902692) |
0.0 | 0.1 | GO:0061462 | protein localization to lysosome(GO:0061462) |
0.0 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.1 | GO:1902775 | mitochondrial ribosome assembly(GO:0061668) mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.0 | GO:0070487 | monocyte aggregation(GO:0070487) |
0.0 | 0.1 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.1 | GO:0034727 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.0 | 0.6 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.0 | 0.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.0 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.0 | 0.0 | GO:0032366 | intracellular sterol transport(GO:0032366) |
0.0 | 0.0 | GO:0014874 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
0.0 | 0.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.0 | 0.1 | GO:0035196 | production of miRNAs involved in gene silencing by miRNA(GO:0035196) |
0.0 | 0.2 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.0 | 0.2 | GO:0045780 | positive regulation of bone resorption(GO:0045780) positive regulation of bone remodeling(GO:0046852) |
0.0 | 0.1 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.0 | 0.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 2.1 | GO:0050953 | sensory perception of light stimulus(GO:0050953) |
0.0 | 0.1 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.1 | GO:0097048 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
0.0 | 0.5 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.0 | 0.4 | GO:0086010 | membrane depolarization during action potential(GO:0086010) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:0050961 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.0 | 1.1 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.4 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.0 | 0.0 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.0 | 0.0 | GO:0070202 | regulation of establishment of protein localization to chromosome(GO:0070202) |
0.0 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.0 | 0.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.0 | 0.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.0 | 0.1 | GO:0043045 | DNA methylation involved in embryo development(GO:0043045) changes to DNA methylation involved in embryo development(GO:1901538) |
0.0 | 0.1 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.1 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.2 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.2 | GO:0006264 | mitochondrial DNA replication(GO:0006264) |
0.0 | 0.3 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.1 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.1 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.0 | 0.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.0 | 0.3 | GO:0008272 | sulfate transport(GO:0008272) |
0.0 | 0.1 | GO:0072201 | negative regulation of mesenchymal cell proliferation(GO:0072201) |
0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.0 | 0.1 | GO:0051095 | regulation of helicase activity(GO:0051095) positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.0 | GO:0021543 | pallium development(GO:0021543) |
0.0 | 0.3 | GO:0060688 | regulation of morphogenesis of a branching structure(GO:0060688) |
0.0 | 0.0 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.0 | 0.1 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.0 | GO:0021523 | somatic motor neuron differentiation(GO:0021523) |
0.0 | 0.2 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.0 | 0.1 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.1 | GO:2001223 | negative regulation of neuron migration(GO:2001223) |
0.0 | 0.1 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.0 | 0.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.0 | GO:0002461 | tolerance induction dependent upon immune response(GO:0002461) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 0.0 | GO:0021898 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
0.0 | 0.0 | GO:0009414 | response to water deprivation(GO:0009414) |
0.0 | 0.0 | GO:1904814 | regulation of protein localization to chromosome, telomeric region(GO:1904814) |
0.0 | 0.0 | GO:0090331 | negative regulation of platelet aggregation(GO:0090331) |
0.0 | 0.0 | GO:0050955 | thermoception(GO:0050955) |
0.0 | 0.2 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.7 | GO:0061178 | regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061178) |
0.0 | 0.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.0 | 0.1 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.0 | 0.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.0 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.0 | 0.0 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) |
0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.0 | 0.0 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.0 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.0 | 0.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.0 | 0.0 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.0 | 0.4 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.1 | GO:0043137 | DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.0 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.0 | 2.7 | GO:0048515 | spermatid differentiation(GO:0048515) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.0 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.0 | 0.1 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.1 | GO:0060033 | anatomical structure regression(GO:0060033) |
0.0 | 0.1 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
0.0 | 0.0 | GO:0030917 | midbrain-hindbrain boundary development(GO:0030917) |
0.0 | 0.1 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.0 | 0.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.0 | 0.1 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.0 | 0.0 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.0 | 0.0 | GO:0048162 | preantral ovarian follicle growth(GO:0001546) multi-layer follicle stage(GO:0048162) |
0.0 | 0.0 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.0 | GO:0033227 | dsRNA transport(GO:0033227) |
0.0 | 0.1 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.0 | 0.1 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 0.0 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.0 | 0.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.0 | 0.1 | GO:0070986 | left/right axis specification(GO:0070986) |
0.0 | 0.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.0 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
0.0 | 0.3 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.2 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 0.0 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.0 | 0.0 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.0 | 0.0 | GO:1903358 | regulation of Golgi organization(GO:1903358) |
0.0 | 0.3 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
0.0 | 0.0 | GO:0045026 | plasma membrane fusion(GO:0045026) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.0 | 0.2 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.0 | 0.1 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0007616 | long-term memory(GO:0007616) |
0.0 | 0.1 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.0 | 0.0 | GO:0010873 | positive regulation of cholesterol esterification(GO:0010873) |
0.0 | 0.0 | GO:0042940 | D-amino acid transport(GO:0042940) |
0.0 | 0.1 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.2 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.0 | GO:0060279 | regulation of ovulation(GO:0060278) positive regulation of ovulation(GO:0060279) |
0.0 | 0.0 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0002760 | positive regulation of antimicrobial humoral response(GO:0002760) |
0.0 | 0.1 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.0 | 0.0 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.0 | GO:0009584 | detection of visible light(GO:0009584) |
0.0 | 0.1 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.0 | 0.0 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.0 | 0.0 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.1 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.0 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.0 | GO:0030886 | regulation of myeloid dendritic cell activation(GO:0030885) negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.0 | 0.0 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.0 | 0.0 | GO:0071472 | cellular response to salt stress(GO:0071472) |
0.0 | 0.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.0 | 0.0 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.0 | 0.3 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.0 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.0 | GO:0072348 | sulfur compound transport(GO:0072348) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.0 | GO:0021877 | forebrain neuron fate commitment(GO:0021877) |
0.0 | 0.0 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
0.0 | 0.0 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
0.0 | 0.1 | GO:0000012 | single strand break repair(GO:0000012) |
0.0 | 0.0 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.0 | 0.0 | GO:0019086 | late viral transcription(GO:0019086) |
0.0 | 0.3 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
0.0 | 0.0 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.0 | 0.1 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.0 | 0.0 | GO:0002159 | desmosome assembly(GO:0002159) |
0.0 | 0.0 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.1 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.0 | 0.0 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.0 | 0.0 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.0 | 0.0 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.0 | 0.1 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
0.0 | 0.0 | GO:0071450 | cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
0.0 | 0.1 | GO:0035510 | DNA dealkylation(GO:0035510) |
0.0 | 0.0 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.0 | GO:0070640 | vitamin D3 metabolic process(GO:0070640) |
0.0 | 0.1 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) |
0.0 | 0.1 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0061098 | positive regulation of protein tyrosine kinase activity(GO:0061098) |
0.0 | 0.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.0 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.0 | 0.0 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.0 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.0 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.0 | 0.0 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.0 | 0.0 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.0 | 0.0 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.0 | 0.1 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.0 | 0.0 | GO:0032687 | negative regulation of interferon-alpha production(GO:0032687) |
0.0 | 0.0 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.0 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.0 | 0.0 | GO:0060969 | negative regulation of gene silencing(GO:0060969) |
0.0 | 0.0 | GO:0071599 | otic vesicle development(GO:0071599) |
0.0 | 0.2 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.1 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.0 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.0 | 0.1 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.0 | 0.0 | GO:1903975 | regulation of glial cell migration(GO:1903975) |
0.0 | 0.0 | GO:0042430 | indole-containing compound metabolic process(GO:0042430) |
0.0 | 0.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.0 | 0.0 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.0 | 0.1 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.1 | GO:0034063 | stress granule assembly(GO:0034063) |
0.0 | 0.2 | GO:0007585 | respiratory gaseous exchange(GO:0007585) |
0.0 | 0.0 | GO:0033685 | negative regulation of luteinizing hormone secretion(GO:0033685) |
0.0 | 0.0 | GO:0060079 | excitatory postsynaptic potential(GO:0060079) |
0.0 | 0.0 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.0 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0045583 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
0.0 | 0.0 | GO:0008655 | pyrimidine-containing compound salvage(GO:0008655) pyrimidine nucleoside salvage(GO:0043097) |
0.0 | 0.0 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.0 | 0.0 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.0 | 0.1 | GO:0050716 | positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.0 | 0.0 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.1 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.1 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.0 | 0.0 | GO:0006642 | triglyceride mobilization(GO:0006642) |
0.0 | 0.0 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.0 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.0 | 0.0 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.0 | GO:0030167 | proteoglycan catabolic process(GO:0030167) |
0.0 | 0.0 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.0 | 0.1 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.0 | 0.0 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.0 | 0.0 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.0 | 0.0 | GO:0038001 | paracrine signaling(GO:0038001) |
0.0 | 0.0 | GO:0009253 | peptidoglycan metabolic process(GO:0000270) peptidoglycan catabolic process(GO:0009253) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 4.8 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
1.4 | 4.2 | GO:0072534 | perineuronal net(GO:0072534) |
1.0 | 3.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.0 | 8.0 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.9 | 3.6 | GO:0044308 | axonal spine(GO:0044308) |
0.8 | 2.5 | GO:0032280 | symmetric synapse(GO:0032280) |
0.8 | 9.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.6 | 12.1 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.6 | 5.7 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.5 | 11.0 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.5 | 1.6 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.5 | 22.5 | GO:0008328 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.5 | 4.1 | GO:0043083 | synaptic cleft(GO:0043083) |
0.5 | 3.4 | GO:0032584 | growth cone membrane(GO:0032584) |
0.5 | 2.4 | GO:0071547 | piP-body(GO:0071547) |
0.5 | 6.7 | GO:0031045 | dense core granule(GO:0031045) |
0.5 | 2.3 | GO:0097433 | dense body(GO:0097433) |
0.4 | 2.1 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.4 | 2.0 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 0.4 | GO:0032010 | phagolysosome(GO:0032010) |
0.4 | 1.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.4 | 2.3 | GO:0030122 | AP-2 adaptor complex(GO:0030122) |
0.4 | 3.2 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 16.1 | GO:0043198 | dendritic shaft(GO:0043198) |
0.3 | 1.0 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.3 | 5.1 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 13.7 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.3 | 1.0 | GO:0044393 | microspike(GO:0044393) |
0.3 | 22.1 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.3 | 1.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.3 | 0.6 | GO:1990635 | proximal dendrite(GO:1990635) |
0.3 | 0.9 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.3 | 2.3 | GO:0030673 | axolemma(GO:0030673) |
0.3 | 6.4 | GO:0044295 | axonal growth cone(GO:0044295) |
0.3 | 2.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.3 | 2.2 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.3 | 4.5 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.3 | 7.7 | GO:0099501 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.3 | 1.3 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.3 | 0.5 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 2.3 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.3 | 0.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.2 | 0.7 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.2 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 14.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.2 | 0.6 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.2 | 8.2 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.2 | GO:0044292 | dendrite terminus(GO:0044292) |
0.2 | 1.6 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.2 | 2.4 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 0.4 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 0.7 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.2 | 0.5 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 0.5 | GO:0033268 | node of Ranvier(GO:0033268) |
0.2 | 2.2 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 0.5 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.2 | 0.2 | GO:0044299 | C-fiber(GO:0044299) |
0.2 | 0.7 | GO:1990131 | EGO complex(GO:0034448) Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.2 | 1.5 | GO:0036156 | inner dynein arm(GO:0036156) |
0.2 | 2.4 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.2 | 2.2 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.2 | 1.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 19.9 | GO:0045211 | postsynaptic membrane(GO:0045211) |
0.1 | 2.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
0.1 | 0.1 | GO:0042827 | platelet dense granule(GO:0042827) |
0.1 | 0.6 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 2.5 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 0.3 | GO:0034705 | potassium channel complex(GO:0034705) |
0.1 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 16.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.4 | GO:0043293 | apoptosome(GO:0043293) |
0.1 | 0.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.1 | 1.5 | GO:0061702 | inflammasome complex(GO:0061702) |
0.1 | 0.5 | GO:0061574 | ASAP complex(GO:0061574) |
0.1 | 2.4 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 1.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 1.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.1 | 7.3 | GO:0043204 | perikaryon(GO:0043204) |
0.1 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.1 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.1 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.2 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 0.6 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 0.5 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 2.6 | GO:0005921 | gap junction(GO:0005921) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.3 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 0.4 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.1 | 2.3 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 8.2 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.2 | GO:0043511 | inhibin complex(GO:0043511) |
0.1 | 0.3 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 0.4 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.6 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.4 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.1 | 0.1 | GO:0005879 | axonemal microtubule(GO:0005879) |
0.1 | 0.4 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.1 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.1 | 0.4 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.7 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.1 | GO:0070852 | cell body fiber(GO:0070852) |
0.1 | 2.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.3 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.1 | 0.6 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.2 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.1 | 0.4 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.7 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 0.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.1 | 0.1 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 0.7 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 20.8 | GO:0036477 | somatodendritic compartment(GO:0036477) |
0.1 | 0.1 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.1 | 0.2 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.2 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.0 | 0.4 | GO:0097060 | synaptic membrane(GO:0097060) |
0.0 | 0.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 0.3 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.0 | 0.0 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
0.0 | 0.4 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.0 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.0 | 0.1 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.0 | 0.9 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.0 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.1 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.0 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.1 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.0 | 0.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.0 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.0 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.6 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 1.0 | GO:0030426 | growth cone(GO:0030426) |
0.0 | 0.1 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.0 | 0.1 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.0 | 0.1 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.0 | 0.3 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.9 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 0.9 | GO:0044297 | cell body(GO:0044297) |
0.0 | 0.9 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 1.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.3 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.4 | GO:0043195 | terminal bouton(GO:0043195) |
0.0 | 0.2 | GO:0034993 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.2 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.0 | 0.3 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 0.0 | GO:0098984 | neuron to neuron synapse(GO:0098984) |
0.0 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.0 | 0.4 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.3 | GO:0005605 | basal lamina(GO:0005605) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.1 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.0 | 0.1 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.0 | 0.2 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.0 | 0.6 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 0.3 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.0 | 0.0 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 0.1 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.0 | 0.9 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.0 | 0.1 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.0 | 0.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.0 | 0.0 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.2 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 0.6 | GO:0030659 | cytoplasmic vesicle membrane(GO:0030659) |
0.0 | 0.1 | GO:0042583 | chromaffin granule(GO:0042583) |
0.0 | 0.2 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.0 | 0.1 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) |
0.0 | 0.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.0 | 0.1 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0097449 | astrocyte projection(GO:0097449) |
0.0 | 0.1 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.0 | GO:0000322 | storage vacuole(GO:0000322) |
0.0 | 0.1 | GO:0098576 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) lumenal side of membrane(GO:0098576) |
0.0 | 0.4 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 15.9 | GO:0005887 | integral component of plasma membrane(GO:0005887) |
0.0 | 3.7 | GO:0099503 | secretory vesicle(GO:0099503) |
0.0 | 0.1 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.0 | 0.5 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.0 | 1.0 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.0 | 0.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.1 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.1 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.1 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.0 | 0.1 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 0.1 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.0 | 0.1 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.0 | 0.1 | GO:0045179 | apical cortex(GO:0045179) |
0.0 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.0 | 0.2 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.1 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.0 | 0.1 | GO:0031143 | pseudopodium(GO:0031143) |
0.0 | 0.2 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.0 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.0 | 0.0 | GO:0000802 | transverse filament(GO:0000802) |
0.0 | 0.1 | GO:0089701 | U2AF(GO:0089701) |
0.0 | 0.2 | GO:1990391 | DNA repair complex(GO:1990391) |
0.0 | 0.1 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 7.8 | GO:0005519 | cytoskeletal regulatory protein binding(GO:0005519) |
1.6 | 4.8 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
1.4 | 4.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.4 | 4.3 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
1.4 | 4.3 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
1.1 | 4.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
1.1 | 6.8 | GO:0004977 | melanocortin receptor activity(GO:0004977) |
1.1 | 3.4 | GO:0048101 | calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
1.1 | 3.3 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
1.1 | 3.3 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.1 | 4.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
1.0 | 4.2 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
1.0 | 5.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.0 | 4.9 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
1.0 | 3.9 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.0 | 2.9 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.9 | 2.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.8 | 5.0 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.8 | 2.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.7 | 2.8 | GO:0016212 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.7 | 4.1 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
0.7 | 4.1 | GO:0030955 | potassium ion binding(GO:0030955) |
0.7 | 12.6 | GO:0031489 | myosin V binding(GO:0031489) |
0.7 | 2.0 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.6 | 9.6 | GO:0031402 | sodium ion binding(GO:0031402) |
0.6 | 4.4 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.6 | 0.6 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.6 | 4.3 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.6 | 9.0 | GO:0022842 | leak channel activity(GO:0022840) narrow pore channel activity(GO:0022842) |
0.6 | 1.8 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.6 | 6.4 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.6 | 0.6 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.6 | 9.5 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.6 | 1.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.5 | 3.2 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.5 | 3.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 2.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.5 | 3.0 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.5 | 6.7 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
0.5 | 1.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.5 | 2.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.5 | 1.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.5 | 0.9 | GO:0031697 | beta-1 adrenergic receptor binding(GO:0031697) |
0.5 | 12.2 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.4 | 8.5 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.4 | 2.2 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 1.2 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.4 | 6.9 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.4 | 3.2 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.4 | 7.2 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 3.5 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.4 | 0.4 | GO:0051378 | serotonin binding(GO:0051378) |
0.4 | 14.7 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.4 | 1.1 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.4 | 1.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.4 | 0.4 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.4 | 3.9 | GO:0005522 | profilin binding(GO:0005522) |
0.3 | 1.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 2.7 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.3 | 1.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.3 | 3.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.3 | 2.6 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.3 | 6.4 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.3 | 0.6 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.3 | 1.3 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.3 | 4.3 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.3 | 1.5 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.3 | 7.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 0.9 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.3 | 0.9 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.3 | 0.9 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.3 | 6.2 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 0.6 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.3 | 2.9 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.3 | 0.9 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.3 | 2.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 3.7 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.3 | 2.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.3 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 4.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.3 | 1.0 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 0.8 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.3 | 0.5 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.3 | 2.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 5.5 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.2 | 1.4 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.2 | 6.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.2 | 1.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.2 | 0.9 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.2 | 0.2 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 1.3 | GO:0003918 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.1 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 3.4 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.8 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 5.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.2 | 1.0 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.2 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 4.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.2 | 2.8 | GO:0004970 | ionotropic glutamate receptor activity(GO:0004970) |
0.2 | 0.6 | GO:0001642 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) group III metabotropic glutamate receptor activity(GO:0001642) |
0.2 | 12.6 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.2 | 0.8 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 0.4 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) calcium-dependent protein kinase regulator activity(GO:0010858) |
0.2 | 1.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 0.7 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.9 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.2 | 1.8 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 5.0 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 1.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.2 | 0.8 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.2 | 0.8 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.2 | 2.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 1.0 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.2 | 4.1 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.2 | 0.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.2 | 0.5 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.2 | 0.8 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.1 | 0.4 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.1 | 0.6 | GO:0004690 | cyclic nucleotide-dependent protein kinase activity(GO:0004690) |
0.1 | 1.6 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.1 | 2.9 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 1.4 | GO:0022821 | potassium ion antiporter activity(GO:0022821) |
0.1 | 3.5 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 1.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.4 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 1.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.5 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.1 | 0.7 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 1.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.1 | 2.1 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.1 | 1.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.1 | 0.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.7 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.1 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 1.6 | GO:0035198 | miRNA binding(GO:0035198) |
0.1 | 0.2 | GO:0015563 | uptake transmembrane transporter activity(GO:0015563) |
0.1 | 0.6 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
0.1 | 1.4 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.1 | GO:0018588 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.1 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.5 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.4 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.1 | 0.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.1 | 1.5 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.1 | 0.9 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 0.2 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.1 | 0.2 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
0.1 | 0.3 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 1.0 | GO:0001135 | transcription factor activity, RNA polymerase II transcription factor recruiting(GO:0001135) |
0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 0.3 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 3.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.1 | 0.3 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
0.1 | 0.4 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.8 | GO:0008430 | selenium binding(GO:0008430) |
0.1 | 0.3 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.1 | 0.5 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.6 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.1 | 4.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.1 | 0.5 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 2.9 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.4 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 0.3 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 2.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.5 | GO:0015198 | oligopeptide transporter activity(GO:0015198) |
0.1 | 0.8 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.1 | 0.9 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 0.7 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 1.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.1 | 0.2 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.1 | 1.2 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.2 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.5 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 3.4 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 1.6 | GO:0008483 | transaminase activity(GO:0008483) |
0.1 | 0.7 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 0.5 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 1.8 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.1 | 0.2 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.8 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.1 | 0.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.2 | GO:0018575 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.7 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.1 | 0.2 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.5 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
0.1 | 0.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.1 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.1 | 0.1 | GO:0038191 | neuropilin binding(GO:0038191) |
0.1 | 3.1 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.1 | 0.2 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.1 | 0.4 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.2 | GO:0004103 | choline kinase activity(GO:0004103) |
0.1 | 1.2 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.2 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.1 | 0.4 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.1 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 2.1 | GO:0005262 | calcium channel activity(GO:0005262) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 3.1 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.1 | 0.1 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 0.3 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.1 | 0.2 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.1 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.1 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.1 | 0.5 | GO:0102336 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.7 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 7.8 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.5 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.1 | 0.3 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.1 | 0.7 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.3 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.1 | 0.1 | GO:0008035 | high-density lipoprotein particle binding(GO:0008035) |
0.1 | 0.1 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.6 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.4 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 0.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 0.2 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 0.1 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
0.1 | 1.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.2 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.1 | 0.6 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 0.3 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 0.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 0.5 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.7 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.1 | 0.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.1 | 0.3 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.1 | 1.2 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.2 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 0.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.2 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.4 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 3.3 | GO:0003774 | motor activity(GO:0003774) |
0.1 | 0.1 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.1 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.1 | 0.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 0.1 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.2 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.6 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 0.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.0 | 1.2 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.3 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.2 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.0 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
0.0 | 0.3 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.4 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 1.4 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.0 | GO:0030172 | troponin C binding(GO:0030172) |
0.0 | 0.2 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 5.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 0.5 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.0 | 1.2 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.0 | 0.2 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 2.6 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.1 | GO:0008142 | oxysterol binding(GO:0008142) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.0 | 0.1 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.0 | 0.0 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
0.0 | 0.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.1 | GO:0050692 | DBD domain binding(GO:0050692) |
0.0 | 0.1 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.0 | 0.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.0 | 0.6 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.0 | 0.2 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.2 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.4 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 1.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
0.0 | 0.1 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.0 | 0.2 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.0 | 0.3 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.0 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.0 | 1.5 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 1.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.1 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) dopamine neurotransmitter receptor activity(GO:0004952) |
0.0 | 0.5 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.1 | GO:0022839 | ion gated channel activity(GO:0022839) |
0.0 | 0.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.0 | 16.3 | GO:0005509 | calcium ion binding(GO:0005509) |
0.0 | 0.1 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.0 | 0.2 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 1.0 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.2 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.0 | 0.3 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.1 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.0 | 0.1 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.0 | 0.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.1 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 0.2 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.0 | 2.5 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0004096 | catalase activity(GO:0004096) |
0.0 | 1.7 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.1 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.0 | 0.1 | GO:0005234 | extracellular-glutamate-gated ion channel activity(GO:0005234) |
0.0 | 0.8 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.0 | 0.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.0 | 0.1 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.0 | 0.1 | GO:1990254 | keratin filament binding(GO:1990254) |
0.0 | 0.6 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.1 | GO:0016019 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0032142 | single guanine insertion binding(GO:0032142) |
0.0 | 0.1 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) peptidyl-proline 3-dioxygenase activity(GO:0031544) |
0.0 | 0.1 | GO:0050693 | LBD domain binding(GO:0050693) |
0.0 | 0.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.1 | GO:0000295 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.0 | 0.2 | GO:0019841 | retinol binding(GO:0019841) |
0.0 | 0.2 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.0 | 0.0 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.0 | 0.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.3 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.1 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.0 | 0.1 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.0 | 0.1 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.7 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.2 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.0 | 3.6 | GO:0003924 | GTPase activity(GO:0003924) |
0.0 | 1.8 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.1 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.2 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.1 | GO:0015368 | calcium:sodium antiporter activity(GO:0005432) calcium:cation antiporter activity(GO:0015368) |
0.0 | 0.0 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.0 | GO:0030519 | snoRNP binding(GO:0030519) |
0.0 | 0.3 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.0 | 0.5 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 0.2 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.0 | 0.0 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.0 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.0 | 0.1 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 2.0 | GO:0003729 | mRNA binding(GO:0003729) |
0.0 | 0.2 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.1 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.0 | 0.0 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.0 | 0.0 | GO:0008312 | 7S RNA binding(GO:0008312) |
0.0 | 0.2 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0004337 | geranyltranstransferase activity(GO:0004337) |
0.0 | 0.0 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.0 | GO:0016751 | S-succinyltransferase activity(GO:0016751) |
0.0 | 0.1 | GO:0005165 | neurotrophin receptor binding(GO:0005165) |
0.0 | 0.0 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.0 | 1.2 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.0 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.0 | 0.2 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
0.0 | 0.1 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.0 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
0.0 | 0.1 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.0 | 0.0 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.0 | 0.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.1 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.0 | 0.1 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 0.0 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.0 | 0.0 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.1 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.0 | GO:1904680 | peptide-transporting ATPase activity(GO:0015440) peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.2 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.0 | 0.0 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.0 | 0.2 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.1 | GO:0015172 | acidic amino acid transmembrane transporter activity(GO:0015172) |
0.0 | 0.2 | GO:0016864 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.0 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.0 | 0.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.0 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.0 | 0.0 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.0 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.0 | GO:0030957 | Tat protein binding(GO:0030957) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.0 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
0.0 | 0.0 | GO:0015491 | cation:cation antiporter activity(GO:0015491) |
0.0 | 0.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.0 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 0.2 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0043855 | intracellular cyclic nucleotide activated cation channel activity(GO:0005221) cyclic nucleotide-gated ion channel activity(GO:0043855) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.0 | 0.0 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.0 | 0.0 | GO:2001070 | starch binding(GO:2001070) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.0 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.0 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.0 | GO:0015065 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.0 | 0.2 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.0 | 0.0 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.0 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.3 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.6 | 3.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.5 | 3.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 3.5 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 2.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.3 | 4.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 0.9 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.3 | 6.6 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 3.6 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.2 | 6.4 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.2 | 6.3 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.2 | 5.4 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.2 | 11.6 | PID NOTCH PATHWAY | Notch signaling pathway |
0.2 | 7.5 | PID BMP PATHWAY | BMP receptor signaling |
0.2 | 1.8 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.2 | 0.9 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 5.2 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 8.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 1.7 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 4.9 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 0.2 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 1.0 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.1 | 1.0 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 3.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.8 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 1.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 3.3 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.4 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 1.1 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.0 | 2.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.3 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 0.1 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.0 | 0.1 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.0 | 5.5 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.5 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 0.5 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.0 | 0.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.0 | 0.2 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.4 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.0 | 0.0 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.5 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 0.2 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 0.4 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.2 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.7 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.1 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 0.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.1 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.0 | 0.2 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.0 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.0 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.4 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.0 | 0.1 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.0 | 0.0 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.0 | 0.0 | PID S1P S1P2 PATHWAY | S1P2 pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 17.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.6 | 6.7 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.6 | 6.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.5 | 14.8 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 4.6 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.5 | 8.9 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.4 | 4.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.4 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.3 | 1.0 | REACTOME DOPAMINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Dopamine Neurotransmitter Release Cycle |
0.3 | 5.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.3 | 2.7 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.3 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.3 | 11.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.3 | 0.8 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 2.2 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.3 | 2.7 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.3 | 3.5 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.3 | 3.7 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.2 | 1.0 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.2 | 0.2 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.2 | 6.5 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.2 | 9.8 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.2 | 3.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 0.9 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.2 | 2.4 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.2 | 2.5 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.2 | 4.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.2 | 0.2 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.9 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 1.8 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.2 | 0.9 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.2 | 2.0 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.2 | 1.7 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.2 | 1.9 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.2 | 1.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.2 | 2.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 3.3 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.1 | 2.5 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.1 | 3.2 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.1 | 2.7 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 0.1 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 1.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.6 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
0.1 | 2.4 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 9.4 | REACTOME G ALPHA S SIGNALLING EVENTS | Genes involved in G alpha (s) signalling events |
0.1 | 1.6 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.1 | 2.2 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 0.8 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.4 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 1.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 1.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 0.5 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 3.0 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 4.9 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 1.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 1.5 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 0.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 0.7 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 0.2 | REACTOME SOS MEDIATED SIGNALLING | Genes involved in SOS-mediated signalling |
0.1 | 1.7 | REACTOME POTASSIUM CHANNELS | Genes involved in Potassium Channels |
0.1 | 1.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.1 | 0.8 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 9.6 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 0.4 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.1 | 0.6 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.1 | 2.5 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.1 | 0.5 | REACTOME SIGNALING BY NOTCH1 | Genes involved in Signaling by NOTCH1 |
0.1 | 0.8 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 1.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.3 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.8 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.6 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.2 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 0.1 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.6 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.9 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.1 | REACTOME ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING | Genes involved in Activation of Kainate Receptors upon glutamate binding |
0.0 | 0.3 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.5 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 0.5 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.0 | 1.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.2 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 0.6 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.0 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.0 | 0.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.0 | 0.1 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.0 | 0.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.1 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.0 | 0.1 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.0 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.2 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.1 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.2 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.0 | 0.1 | REACTOME AXON GUIDANCE | Genes involved in Axon guidance |
0.0 | 0.1 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.1 | REACTOME SHC MEDIATED SIGNALLING | Genes involved in SHC-mediated signalling |
0.0 | 0.0 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.0 | 0.0 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.0 | 0.1 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.0 | 0.0 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.0 | 0.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 0.2 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.1 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 1.3 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.0 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.1 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.0 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.0 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |